Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $21.8 million.

  • Mesa Laboratories' Non-Current Deferred Tax Liability rose 817.6% to $21.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.8 million, marking a year-over-year increase of 817.6%. This contributed to the annual value of $20.2 million for FY2025, which is 202.73% up from last year.
  • Per Mesa Laboratories' latest filing, its Non-Current Deferred Tax Liability stood at $21.8 million for Q4 2025, which was up 817.6% from $21.7 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Non-Current Deferred Tax Liability registered a high of $44.3 million during Q4 2023, and its lowest value of $10.8 million during Q2 2021.
  • Over the past 5 years, Mesa Laboratories' median Non-Current Deferred Tax Liability value was $21.7 million (recorded in 2025), while the average stood at $27.0 million.
  • As far as peak fluctuations go, Mesa Laboratories' Non-Current Deferred Tax Liability tumbled by 6537.3% in 2021, and later skyrocketed by 24513.59% in 2022.
  • Over the past 5 years, Mesa Laboratories' Non-Current Deferred Tax Liability (Quarter) stood at $41.1 million in 2021, then fell by 10.18% to $36.9 million in 2022, then grew by 20.01% to $44.3 million in 2023, then tumbled by 54.49% to $20.2 million in 2024, then grew by 8.18% to $21.8 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $21.8 million for Q4 2025, versus $21.7 million for Q3 2025 and $21.6 million for Q2 2025.